Mingxia Zhou
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
- Cancer-related gene regulation
- Gut microbiota and health
Papers in
-
- RNA modifications and cancer 8
- Circular RNAs in diseases 6
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 5
- Co-authors
- Yingwei Chen (8 shared papers)Fucheng He (14 shared papers)Yingying Shi (4 shared papers)Peng Du (5 shared papers)Jing He (12 shared papers)Wensong Ge (2 shared papers)Weimin Xu (3 shared papers)Junkai Yan (2 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Journal of Experimental & Clinical Cancer Research (3 papers)Cell Death and Disease (3 papers)Plant Disease (2 papers)Toxins (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Mingxia Zhou
46 papers receiving 1.5k citations
Mingxia Zhou's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 335
- Molecular Biology 831
- Immunology 205
- Oncology 112
- Epidemiology 133
Countries citing papers authored by Mingxia Zhou
This map shows the geographic impact of Mingxia Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Zhou more than expected).
Fields of papers citing papers by Mingxia Zhou
This network shows the impact of papers produced by Mingxia Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Zhou. The network helps show where Mingxia Zhou may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingxia Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury Hit paper breakdown → | 2018 | 284 |
| 2 | 2021 | 134 | |
| 3 | 2014 | 93 | |
| 4 | 2021 | 81 | |
| 5 | 2017 | 75 | |
| 6 | 2016 | 72 | |
| 7 | 2022 | 68 | |
| 8 | 2015 | 55 | |
| 9 | 2020 | 50 | |
| 10 | 2019 | 50 | |
| 11 | 2022 | 40 | |
| 12 | 2019 | 40 | |
| 13 | 2020 | 38 | |
| 14 | 2011 | 35 | |
| 15 | 2015 | 33 | |
| 16 | 2017 | 32 | |
| 17 | 2023 | 26 | |
| 18 | 2023 | 23 | |
| 19 | 2023 | 19 | |
| 20 | 2022 | 18 |
About Mingxia Zhou
Mingxia Zhou is a scholar working on Molecular Biology, Cancer Research, Plant Science, Genetics and Immunology, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (6 papers), Circular RNAs in diseases (6 papers), MicroRNA in disease regulation (5 papers), Plant-Microbe Interactions and Immunity (4 papers), Inflammatory Bowel Disease (4 papers), Epigenetics and DNA Methylation (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Cancer Research (335 citations), Molecular Biology (831 citations), Immunology (205 citations), Oncology (112 citations) and Epidemiology (133 citations). Mingxia Zhou has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yingwei Chen, Fucheng He, Yingying Shi, Peng Du, Jing He, Wensong Ge, Weimin Xu, Junkai Yan, Cong Zhang and Jin Wu. Their work appears in journals such as International Journal of Molecular Sciences, Journal of Experimental & Clinical Cancer Research, Cell Death and Disease, Plant Disease and Toxins.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.